.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Julphar
Colorcon
Chinese Patent Office
Teva
Merck
Dow
Express Scripts
QuintilesIMS

Generated: February 20, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Israel Patent: 155588

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
PfizerELELYSOtaliglucerase alfaPOWDER;IV (INFUSION)022458-001May 1, 2012RXYesYes➤ Try a Free Trial➤ Try a Free TrialYY
PfizerELELYSOtaliglucerase alfaPOWDER;IV (INFUSION)022458-001May 1, 2012RXYesYes➤ Try a Free Trial➤ Try a Free TrialA METHOD OF TREATING GAUCHER'S DISEASE
PfizerELELYSOtaliglucerase alfaPOWDER;IV (INFUSION)022458-001May 1, 2012RXYesYes➤ Try a Free Trial➤ Try a Free TrialA METHOD OF CATALYZING THE HYDROLYSIS OF GLUCOCEREBROSIDE TO GLUCOSE AND CERAMIDE.
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist